Black Diamond Therapeutics, Inc. Net Cash Provided by (Used in) Investing Activities in USD from 2018 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Summary
Black Diamond Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate from 2018 to Q1 2025.
  • Black Diamond Therapeutics, Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending March 31, 2025 was $8.55M.
  • Black Diamond Therapeutics, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2024 was $17M, a 3.81% increase from 2023.
  • Black Diamond Therapeutics, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2023 was $16.3M, a 69.4% decline from 2022.
  • Black Diamond Therapeutics, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2022 was $53.4M, a 59.1% decline from 2021.
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Investing Activities, Annual (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Annual Growth (%)

Black Diamond Therapeutics, Inc. Quarterly Net Cash Provided by (Used in) Investing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $8.55M +$22.3M Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-12
Q1 2024 -$13.7M -$38.5M -155% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-12
Q1 2023 $24.8M +$8.08M +48.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q1 2022 $16.7M +$13.3M +382% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q1 2021 $3.47M +$3.47M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q1 2020 $0 +$10K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q1 2019 -$10K* Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12

Black Diamond Therapeutics, Inc. Annual Net Cash Provided by (Used in) Investing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $17M +$622K +3.81% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-06
2023 $16.3M -$37M -69.4% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-06
2022 $53.4M -$77.2M -59.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-12
2021 $131M +$412M Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 -$282M -$282M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-17
2019 -$21K* +$55K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-25
2018 -$76K Jan 1, 2018 Dec 31, 2018 10-K 2020-03-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.